首頁 > 市場調查報告書 > 食物/飲料

機能性食品

市場調查報告書

商品編碼

2106364

草本舒壓產品市場預測（2034 年）－按產品類型、成分、劑型、通路、最終用戶和地區分類的全球分析

Herbal Stress Relief Products Market Forecasts to 2034 - Global Analysis By Product Type, Ingredient, Form, Distribution Channel, End User and By Geography

出版日期: 2026年08月01日 | 出版商:

Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

全球草藥舒緩壓力產品市場預計到 2026 年將達到 9 億美元，並在預測期內以 8.8% 的複合年成長率成長，到 2034 年將達到 15 億美元。

草本舒壓產品是從植物萃取物、適應原草藥和傳統藥用植物中提取的天然保健品，旨在緩解焦慮、促進放鬆並維持心理平衡，無需藥物干預。這些產品包括膳食補充劑、功能性茶飲、精油、酊劑和外用製劑，含有諸如醉茄內酯、纈草酸和芹菜素等生物活性物質，能夠調節神經傳導物質活性和皮質醇水平。該技術採用標準化的萃取過程、植物化學成分分析和品管調查方法，以確保產品功效和安全性的一致性。

心理健康意識

隨著全球對心理健康的關注度不斷提高，以及與壓力相關的疾病污名化現象逐漸消退，消費者對便捷易得、無需處方箋即可獲得的健康解決方案——草本舒壓產品的需求激增。職場倦怠、資訊過載以及後疫情時代的焦慮，使得壓力管理成為各個年齡層的日常話題。對成癮性和副作用的擔憂，促使消費者越來越傾向於選擇天然植物來源替代品，而非處方抗焦慮藥物。在企業健康計畫和醫療保健專業人士的鼓勵下，終端使用者正將適應原草藥作為預防保健手段。在商業性，主流趨勢正從被動用藥轉向主動預防的植物來源健康療法，零售和直銷通路也不斷拓展。

法規差異

在國際市場上，缺乏統一的草藥補充劑功效聲明和品質標準法律規範，嚴重阻礙了市場擴張和消費者信任的建立。美國FDA將此類產品歸類為膳食補充劑，上市前核准要求有限；而歐盟則根據EFSA指南，對植物來源的健康聲明實施更為嚴格的監管。可接受的行銷聲明、建議最大攝取量以及成分安全評估的差異，使得全球產品上市更加複雜。這些監管差異增加了跨國品牌的合規成本，也讓消費者對產品的功效和安全性感到困惑。

個人化處方

個人化營養和人工智慧驅動的健康平台的興起，為草本舒壓產品創造了變革性的機遇，這些產品可根據個人基因譜、生活方式因素和壓力生物標記進行客製化。直接面對消費者 (D2C) 的品牌正在利用線上問卷調查、微生物組檢測和皮質醇監測來推薦特定的適應原混合物。訂閱模式確保了持續的收入，同時建立了長期的客戶關係。終端用戶受益於針對其獨特壓力源的定向配方，而不是通用的「一刀切」產品。市場趨勢青睞那些將數據驅動的個人化服務作為高階差異化策略的品牌。

與製藥業的競爭

非處方和處方壓力管理藥物的持續研發和市場推廣，對草藥舒緩壓力產品構成了持續的競爭威脅。製藥公司在臨床試驗和醫生培訓計畫上投入大量資金，使其擁有大多數草藥品牌無法匹敵的信譽。改良版抗焦慮藥物的非專利藥降低了成本，提高了可及性。法律規範通常傾向於優先考慮具有臨床證據支持的藥物，而非草藥替代品。這種情況迫使草藥品牌投入高昂的臨床研究成本，才能在主流醫療保健管道中有效競爭。

新型冠狀病毒（COVID-19）的影響：

新冠疫情引發的健康擔憂、經濟不確定性和社會隔離顯著加劇了全球壓力水平，導致草本舒壓產品需求空前高漲。供應鏈中斷影響了南非睡茄和洋甘菊等關鍵植物成分的採購。由於疫情期間零售商店面臨營運限制，電商通路成為主要通路。疫情結束後，人們對心理健康和預防性自我護理的意識增強，消費者得以繼續維持疫情期間養成的壓力管理習慣，從而推動了市場持續成長。

在預測期內，草藥補充劑細分市場預計將佔據最大的市場佔有率。

由於膠囊和片劑等劑型相比其他劑型具有服用方便、劑量精準、保存期限長等優點，預計草藥補充劑在預測期內將佔據最大的市場佔有率。草藥補充劑憑藉消費者對其的熟悉度和醫療保健專業人士的推薦，在零售藥局和保健食品商店的貨架上佔據主導地位。標準化萃取物確保了生物活性成分濃度的一致性，吸引了注重實證醫學的消費者。終端用戶重視補充劑的便攜性和隱蔽性。該領域的商業性主導地位反映了市場的成熟度、廣泛的分銷網路以及在全球市場上強大的品牌知名度。

預計在預測期內，睡茄細分市場將錄得最高的複合年成長率。

在預測期內，睡茄）細分市場預計將呈現最高的成長率，這主要得益於其適應原特性的可靠臨床檢驗以及消費者對其作為領先的壓力管理植物的認知度不斷提高。經同行評審的研究表明，南非睡茄根萃取物（包括標準化的醉茄內酯濃度）能夠顯著降低皮質醇水平。其產品形式多樣，包括膠囊、粉末、軟糖和機能飲料，正在加速其在各種應用場景中的普及。與其他適應原相比，印度本土生產具有成本優勢。主要市場的法規核准支持其廣泛的商業性分銷，而持續的研究也不斷證實其新應用的有效性。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於成熟的膳食補充劑行業、消費者在健康產品上的高支出以及完善的零售分銷系統。美國憑藉著成熟的直銷品牌、強大的電商平台以及醫療保健專業人士對植物性補充劑的大力支持，在市場中處於領先地位。加拿大受益於類似的消費者偏好，以及支持天然保健品的法律規範。在墨西哥，不斷壯大的中產階級和日益增強的健康意識正在創造新的需求。該地區先進的物流網路能夠實現高效的全通路分銷。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於阿育吠陀和傳統中醫草藥療法的悠久歷史、可支配收入的成長以及印度、中國和東南亞現代零售管道的擴張。印度已成為睡茄和其他重要適應原草藥的全球生產中心。在中國，傳統植物知識與現代保健品生產技術的融合正在創造一系列獨特的產品。在日本和韓國，消費者對含有具有舒緩壓力功效的植物成分的功能性食品和飲料的接受度已得到證實。政府對傳統醫學現代化的支持正在加速市場發展。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

企業概況
- 對其他市場參與者（最多 3 家公司）進行全面分析
- 對主要公司進行SWOT分析（最多3家公司）
區域分類
- 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
競爭性標竿分析
- 根據產品系列、企業發展和策略聯盟對重點公司進行基準分析。

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 比利時
- 瑞典
- 瑞士
- 波蘭
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 印尼
- 泰國
- 馬來西亞
- 新加坡
- 越南
- 其他亞太國家
南美洲
- 巴西
- 阿根廷
- 哥倫比亞
- 智利
- 秘魯
- 其他南美國家
世界其他地區（RoW）
- 中東
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 卡達
  - 以色列
  - 其他中東國家
- 非洲
  - 南非
  - 埃及
  - 摩洛哥
  - 其他非洲國家

第11章策略市場資訊

工業價值網路和供應鏈評估
空白區域和機會地圖
產品演進與市場生命週期分析
通路、經銷商和打入市場策略的評估

第12章產業趨勢與策略舉措

併購
夥伴關係、聯盟和合資企業
新產品發布和認證
擴大生產能力和投資
其他策略舉措

第13章：公司簡介

Himalaya Wellness Company
Dabur India Ltd.
Herb Pharm
Nature's Way Products, LLC
Gaia Herbs
Traditional Medicinals
Organic India Pvt. Ltd.
Now Health Group, Inc.
The Nature's Bounty Co.
Garden of Life
Blackmores Limited
Swisse Wellness Pty Ltd.
Arkopharma Laboratories
Pukka Herbs Ltd.
Boiron Group
Solaray
Integria Healthcare

簡介目錄圖表

Product Code: SMRC38501

According to Stratistics MRC, the Global Herbal Stress Relief Products Market is accounted for $0.9 billion in 2026 and is expected to reach $1.5 billion by 2034 growing at a CAGR of 8.8% during the forecast period. Herbal stress relief products are natural wellness formulations derived from botanical extracts, adaptogenic herbs, and traditional medicinal plants designed to alleviate anxiety, promote relaxation, and support mental equilibrium without pharmaceutical intervention. These products encompass dietary supplements, functional teas, essential oils, tinctures, and topical applications containing bioactive compounds such as withanolides, valerenic acid, and apigenin that modulate neurotransmitter activity and cortisol regulation. The technology encompasses standardized extraction processes, phytochemical profiling, and quality control methodologies that ensure consistent potency and safety.

Market Dynamics:

Driver:

Mental health awareness

The global surge in mental health awareness and destigmatization of stress-related conditions is driving substantial consumer demand for herbal stress relief products as accessible, non-prescription wellness solutions. Workplace burnout, digital overload, and post-pandemic anxiety have normalized conversations about stress management across all age groups. Consumers increasingly prefer natural, plant-based alternatives to pharmaceutical anxiolytics due to concerns about dependency and side effects. End users in corporate wellness programs and healthcare recommendations embrace adaptogenic herbs as preventive care tools. The commercial implication is a mainstream shift from reactive medication to proactive botanical wellness, expanding retail and direct-to-consumer distribution channels.

Restraint:

Regulatory variability

The inconsistent regulatory frameworks governing herbal supplement claims and quality standards across international markets create significant barriers to market expansion and consumer trust. The United States FDA classifies these products as dietary supplements with limited pre-market approval requirements, while the European Union enforces stricter botanical health claim regulations under EFSA guidelines. Variations in permissible marketing language, maximum dosage recommendations, and ingredient safety assessments complicate global product launches. These regulatory disparities increase compliance costs for multinational brands and create confusion among consumers regarding product efficacy and safety profiles.

Opportunity:

Personalized formulations

The emergence of personalized nutrition and artificial intelligence-driven wellness platforms is creating transformative opportunities for customized herbal stress relief products tailored to individual genetic profiles, lifestyle factors, and stress biomarkers. Direct-to-consumer brands leverage online questionnaires, microbiome testing, and cortisol monitoring to recommend specific adaptogenic blends. Subscription-based models ensure recurring revenue while building long-term customer relationships. End users benefit from targeted formulations that address their unique stress triggers rather than generic one-size-fits-all products. The commercial momentum favors brands offering data-driven personalization as a premium differentiation strategy.

Threat:

Pharmaceutical competition

The continuous development and marketing of over-the-counter and prescription stress management medications poses a persistent competitive threat to herbal stress relief products. Pharmaceutical companies invest heavily in clinical trials and physician education programs that establish credibility beyond the reach of most botanical brands. Improved generic formulations of established anxiolytics reduce costs and increase accessibility. Regulatory frameworks often favor pharmaceutical products with documented clinical evidence over herbal alternatives. These dynamics compel herbal brands to invest in costly clinical research to compete effectively in mainstream healthcare channels.

Covid-19 Impact:

The COVID-19 pandemic significantly elevated global stress levels due to health concerns, economic uncertainty, and social isolation, creating unprecedented demand for herbal stress relief products. Supply chain disruptions affected raw material sourcing for key botanicals such as ashwagandha and chamomile. Mid-pandemic, e-commerce channels became the primary distribution pathway as retail stores faced restrictions. Post-pandemic, sustained awareness of mental wellness and preventive self-care supports continued market growth as consumers maintain stress management routines established during the crisis.

The herbal supplements segment is expected to be the largest during the forecast period

The herbal supplements segment is expected to account for the largest market share during the forecast period, due to the convenience, precise dosing, and extended shelf life that capsule and tablet formats offer compared to other delivery mechanisms. Herbal supplements dominate retail pharmacy and health food store shelves, benefiting from established consumer familiarity and healthcare practitioner recommendations. Standardized extracts ensure consistent bioactive compound concentrations, which appeals to evidence-oriented consumers. End users prioritize portability and discretion in supplement consumption. The commercial dominance reflects the segment's maturity, broad distribution network, and strong brand recognition across global markets.

The ashwagandha segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the ashwagandha segment is predicted to witness the highest growth rate, driven by robust clinical validation of its adaptogenic properties and expanding consumer recognition as a primary stress management botanical. Ashwagandha root extracts containing standardized withanolide concentrations demonstrate measurable cortisol reduction in peer-reviewed studies. The ingredient's versatility across capsules, powders, gummies, and functional beverages accelerates cross-format adoption. Indian domestic production scales provide cost advantages relative to other adaptogens. Regulatory acceptance in major markets supports broad commercial distribution, while ongoing research continues to validate new applications.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the mature dietary supplement industry, high consumer spending on wellness products, and extensive retail distribution infrastructure. The United States leads with established direct-to-consumer brands, robust e-commerce platforms, and strong healthcare practitioner endorsement of botanical supplements. Canada benefits from similar consumer preferences and regulatory frameworks that support natural health products. Mexico's growing middle class and increasing health awareness create emerging demand. The region's advanced logistics networks enable efficient omnichannel distribution.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to the traditional roots of herbal medicine in Ayurvedic and Traditional Chinese Medicine systems, rising disposable incomes, and expanding modern retail channels across India, China, and Southeast Asia. India serves as the global production hub for ashwagandha and other key adaptogenic herbs. China's integration of traditional botanical knowledge with modern supplement manufacturing creates unique product offerings. Japan and South Korea demonstrate strong consumer acceptance of functional foods and beverages containing stress-relief botanicals. Government support for traditional medicine modernization accelerates market development.

Key players in the market

Some of the key players in Herbal Stress Relief Products include Himalaya Wellness Company, Dabur India Ltd., Herb Pharm, Nature's Way Products, LLC, Gaia Herbs, Traditional Medicinals, Organic India Pvt. Ltd., Now Health Group, Inc., The Nature's Bounty Co., Garden of Life, Blackmores Limited, Swisse Wellness Pty Ltd., Arkopharma Laboratories, Pukka Herbs Ltd., Boiron Group, Solaray and Integria Healthcare.

Key Developments:

In June 2026, Himalaya Wellness Company launched a next-generation ashwagandha stress relief supplement with enhanced bioavailability technology, achieving clinically validated cortisol reduction metrics in a twelve-week consumer trial across diverse demographic groups.

In May 2026, Dabur India Ltd. expanded its herbal stress relief product line to European markets, securing EU regulatory compliance for its flagship ashwagandha and Brahmi formulations through comprehensive safety and efficacy documentation.

In April 2026, Gaia Herbs introduced a certified organic adaptogenic blend targeting working professionals, combining ashwagandha, rhodiola, and holy basil in a novel liquid capsule format for enhanced absorption and convenience.

Product Types Covered:

Herbal Supplements
Herbal Teas
Essential Oils
Tinctures and Extracts
Gummies
Powders
Other Product Types

Ingredients Covered:

Ashwagandha
Valerian Root
Chamomile
Lavender
Lemon Balm
Other Ingredients

Forms Covered:

Capsules
Tablets
Liquid
Powder
Gummies
Tea Bags
Essential Oil Blends

Distribution Channels Covered:

Pharmacies and Drug Stores
Supermarkets and Hypermarkets
Health Food Stores
Online Retail
Specialty Stores
Direct Sales

End Users Covered:

Adults
Geriatric Population
Working Professionals
Students
Athletes
Other End Users

Regions Covered:

North America
- United States
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Netherlands
- Belgium
- Sweden
- Switzerland
- Poland
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Vietnam
- Rest of Asia Pacific
South America
- Brazil
- Argentina
- Colombia
- Chile
- Peru
- Rest of South America
Rest of the World (RoW)
- Middle East
Saudi Arabia
United Arab Emirates
Qatar
Israel
Rest of Middle East
- Africa
South Africa
Egypt
Morocco
Rest of Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations

2 Research Framework

2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
- 2.4.1 Data Collection (Primary and Secondary)
- 2.4.2 Data Modeling and Estimation Techniques
- 2.4.3 Data Validation and Triangulation
- 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

4.1 Porter's Five Forces Analysis
- 4.1.1 Supplier Bargaining Power
- 4.1.2 Buyer Bargaining Power
- 4.1.3 Threat of Substitutes
- 4.1.4 Threat of New Entrants
- 4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison

5 Global Herbal Stress Relief Products Market, By Product Type

5.1 Herbal Supplements
5.2 Herbal Teas
5.3 Essential Oils
5.4 Tinctures and Extracts
5.5 Gummies
5.6 Powders
5.7 Other Product Types

6 Global Herbal Stress Relief Products Market, By Ingredient

6.1 Ashwagandha
6.2 Valerian Root
6.3 Chamomile
6.4 Lavender
6.5 Lemon Balm
6.6 Other Ingredients

7 Global Herbal Stress Relief Products Market, By Form

7.1 Capsules
7.2 Tablets
7.3 Liquid
7.4 Powder
7.5 Gummies
7.6 Tea Bags
7.7 Essential Oil Blends

8 Global Herbal Stress Relief Products Market, By Distribution Channel

8.1 Pharmacies and Drug Stores
8.2 Supermarkets and Hypermarkets
8.3 Health Food Stores
8.4 Online Retail
8.5 Specialty Stores
8.6 Direct Sales

9 Global Herbal Stress Relief Products Market, By End User

9.1 Adults
9.2 Geriatric Population
9.3 Working Professionals
9.4 Students
9.5 Athletes
9.6 Other End Users

10 Global Herbal Stress Relief Products Market, By Geography

10.1 North America
- 10.1.1 United States
- 10.1.2 Canada
- 10.1.3 Mexico
10.2 Europe
- 10.2.1 United Kingdom
- 10.2.2 Germany
- 10.2.3 France
- 10.2.4 Italy
- 10.2.5 Spain
- 10.2.6 Netherlands
- 10.2.7 Belgium
- 10.2.8 Sweden
- 10.2.9 Switzerland
- 10.2.10 Poland
- 10.2.11 Rest of Europe
10.3 Asia Pacific
- 10.3.1 China
- 10.3.2 Japan
- 10.3.3 India
- 10.3.4 South Korea
- 10.3.5 Australia
- 10.3.6 Indonesia
- 10.3.7 Thailand
- 10.3.8 Malaysia
- 10.3.9 Singapore
- 10.3.10 Vietnam
- 10.3.11 Rest of Asia Pacific
10.4 South America
- 10.4.1 Brazil
- 10.4.2 Argentina
- 10.4.3 Colombia
- 10.4.4 Chile
- 10.4.5 Peru
- 10.4.6 Rest of South America
10.5 Rest of the World (RoW)
- 10.5.1 Middle East
  - 10.5.1.1 Saudi Arabia
  - 10.5.1.2 United Arab Emirates
  - 10.5.1.3 Qatar
  - 10.5.1.4 Israel
  - 10.5.1.5 Rest of Middle East
- 10.5.2 Africa
  - 10.5.2.1 South Africa
  - 10.5.2.2 Egypt
  - 10.5.2.3 Morocco
  - 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

11.1 Industry Value Network and Supply Chain Assessment
11.2 White-Space and Opportunity Mapping
11.3 Product Evolution and Market Life Cycle Analysis
11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

12.1 Mergers and Acquisitions
12.2 Partnerships, Alliances, and Joint Ventures
12.3 New Product Launches and Certifications
12.4 Capacity Expansion and Investments
12.5 Other Strategic Initiatives

13 Company Profiles

13.1 Himalaya Wellness Company
13.2 Dabur India Ltd.
13.3 Herb Pharm
13.4 Nature's Way Products, LLC
13.5 Gaia Herbs
13.6 Traditional Medicinals
13.7 Organic India Pvt. Ltd.
13.8 Now Health Group, Inc.
13.9 The Nature's Bounty Co.
13.10 Garden of Life
13.11 Blackmores Limited
13.12 Swisse Wellness Pty Ltd.
13.13 Arkopharma Laboratories
13.14 Pukka Herbs Ltd.
13.15 Boiron Group
13.16 Solaray
13.17 Integria Healthcare

簡介目錄圖表

List of Tables

Table 1 Global Herbal Stress Relief Products Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global Herbal Stress Relief Products Market Outlook, By Product Type (2023-2034) ($MN)
Table 3 Global Herbal Stress Relief Products Market Outlook, By Herbal Supplements (2023-2034) ($MN)
Table 4 Global Herbal Stress Relief Products Market Outlook, By Herbal Teas (2023-2034) ($MN)
Table 5 Global Herbal Stress Relief Products Market Outlook, By Essential Oils (2023-2034) ($MN)
Table 6 Global Herbal Stress Relief Products Market Outlook, By Tinctures and Extracts (2023-2034) ($MN)
Table 7 Global Herbal Stress Relief Products Market Outlook, By Gummies (2023-2034) ($MN)
Table 8 Global Herbal Stress Relief Products Market Outlook, By Powders (2023-2034) ($MN)
Table 9 Global Herbal Stress Relief Products Market Outlook, By Other Product Types (2023-2034) ($MN)
Table 10 Global Herbal Stress Relief Products Market Outlook, By Ingredient (2023-2034) ($MN)
Table 11 Global Herbal Stress Relief Products Market Outlook, By Ashwagandha (2023-2034) ($MN)
Table 12 Global Herbal Stress Relief Products Market Outlook, By Valerian Root (2023-2034) ($MN)
Table 13 Global Herbal Stress Relief Products Market Outlook, By Chamomile (2023-2034) ($MN)
Table 14 Global Herbal Stress Relief Products Market Outlook, By Lavender (2023-2034) ($MN)
Table 15 Global Herbal Stress Relief Products Market Outlook, By Lemon Balm (2023-2034) ($MN)
Table 16 Global Herbal Stress Relief Products Market Outlook, By Other Ingredients (2023-2034) ($MN)
Table 17 Global Herbal Stress Relief Products Market Outlook, By Form (2023-2034) ($MN)
Table 18 Global Herbal Stress Relief Products Market Outlook, By Capsules (2023-2034) ($MN)
Table 19 Global Herbal Stress Relief Products Market Outlook, By Tablets (2023-2034) ($MN)
Table 20 Global Herbal Stress Relief Products Market Outlook, By Liquid (2023-2034) ($MN)
Table 21 Global Herbal Stress Relief Products Market Outlook, By Powder (2023-2034) ($MN)
Table 22 Global Herbal Stress Relief Products Market Outlook, By Gummies (2023-2034) ($MN)
Table 23 Global Herbal Stress Relief Products Market Outlook, By Tea Bags (2023-2034) ($MN)
Table 24 Global Herbal Stress Relief Products Market Outlook, By Essential Oil Blends (2023-2034) ($MN)
Table 25 Global Herbal Stress Relief Products Market Outlook, By Distribution Channel (2023-2034) ($MN)
Table 26 Global Herbal Stress Relief Products Market Outlook, By Pharmacies and Drug Stores (2023-2034) ($MN)
Table 27 Global Herbal Stress Relief Products Market Outlook, By Supermarkets and Hypermarkets (2023-2034) ($MN)
Table 28 Global Herbal Stress Relief Products Market Outlook, By Health Food Stores (2023-2034) ($MN)
Table 29 Global Herbal Stress Relief Products Market Outlook, By Online Retail (2023-2034) ($MN)
Table 30 Global Herbal Stress Relief Products Market Outlook, By Specialty Stores (2023-2034) ($MN)
Table 31 Global Herbal Stress Relief Products Market Outlook, By Direct Sales (2023-2034) ($MN)
Table 32 Global Herbal Stress Relief Products Market Outlook, By End User (2023-2034) ($MN)
Table 33 Global Herbal Stress Relief Products Market Outlook, By Adults (2023-2034) ($MN)
Table 34 Global Herbal Stress Relief Products Market Outlook, By Geriatric Population (2023-2034) ($MN)
Table 35 Global Herbal Stress Relief Products Market Outlook, By Working Professionals (2023-2034) ($MN)
Table 36 Global Herbal Stress Relief Products Market Outlook, By Students (2023-2034) ($MN)
Table 37 Global Herbal Stress Relief Products Market Outlook, By Athletes (2023-2034) ($MN)
Table 38 Global Herbal Stress Relief Products Market Outlook, By Other End Users (2023-2034) ($MN)